Apalutamide in prostate cancer: indication of considerable added benefit

(Institute for Quality and Efficiency in Health Care) Symptomatic progression is significantly retarded by this drug. This advantage clearly outweighs the disadvantages presented by some side effects.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news